LUNG vs NSC · rev $43.3M vs P/E 18, rev $6.46B
Pulmonx Corp (LUNG) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Latest reported LUNG revenue for 2026-06-30 was $43.3M. Net income was -$23.7M. LUNG currently screens at market cap $111.9M.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
LUNG currently screens at market cap $111.9M. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the LUNG and NSC stock pages for the full models.
Not investment advice.